Michael Magnotti1, Mona Shimshi. 1. Department of Endocrinology, Mount Sinai Medical Center, New York, New York, USA.
Abstract
OBJECTIVE: To review the available literature on the low-dose cosyntropin stimulation test (CST) for the diagnosis of primary and secondary adrenal insufficiency in both nonstressed and acutely ill patients. METHODS: We performed a MEDLINE search of all English-language literature, published between 1965 and 2007, in which the 1-microg and the 250-microg CSTs were compared in patients with primary and secondary adrenal insufficiency. RESULTS: The majority of published evidence suggests that the 1-microg CST is more sensitive than the 250-microg CST for the diagnosis of secondary adrenal insufficiency in nonstressed patients. In patients with primary adrenal insufficiency, the low-dose CST is unlikely to add any diagnostic sensitivity to the high-dose CST. In critically ill patients, the 1-microg test is also likely to be more sensitive than the 250-microg test when an appropriate cutoff value is used (25 microg/dL). CONCLUSION: The 1-microg CST with a cortisol level determined at 30 minutes after stimulation, with use of a cutoff level of 18 to 20 microg/dL in nonstressed patients and less than 25 microg/dL or an increment of less than 9 microg/dL from baseline in critically ill patients, is the best test that is currently available for establishing the diagnosis of secondary adrenal insufficiency.
OBJECTIVE: To review the available literature on the low-dose cosyntropin stimulation test (CST) for the diagnosis of primary and secondary adrenal insufficiency in both nonstressed and acutely ill patients. METHODS: We performed a MEDLINE search of all English-language literature, published between 1965 and 2007, in which the 1-microg and the 250-microg CSTs were compared in patients with primary and secondary adrenal insufficiency. RESULTS: The majority of published evidence suggests that the 1-microg CST is more sensitive than the 250-microg CST for the diagnosis of secondary adrenal insufficiency in nonstressed patients. In patients with primary adrenal insufficiency, the low-dose CST is unlikely to add any diagnostic sensitivity to the high-dose CST. In critically illpatients, the 1-microg test is also likely to be more sensitive than the 250-microg test when an appropriate cutoff value is used (25 microg/dL). CONCLUSION: The 1-microg CST with a cortisol level determined at 30 minutes after stimulation, with use of a cutoff level of 18 to 20 microg/dL in nonstressed patients and less than 25 microg/dL or an increment of less than 9 microg/dL from baseline in critically illpatients, is the best test that is currently available for establishing the diagnosis of secondary adrenal insufficiency.
Authors: Seenia Peechakara; James Bena; Nigel J Clarke; Michael J McPhaul; Richard E Reitz; Robert J Weil; Pablo Recinos; Laurence Kennedy; Amir H Hamrahian Journal: Endocrine Date: 2017-07-20 Impact factor: 3.633
Authors: L Kebapcilar; O Bilgir; A Alacacioglu; Y Yildiz; A Taylan; R Gunaydin; A Yuksel; B Karaca; I Sari Journal: J Endocrinol Invest Date: 2009-07-20 Impact factor: 4.256
Authors: R S Wijesurendra; F Bernard; J Outtrim; B Maiya; S Joshi; P J Hutchinson; D J Halsall; D K Menon Journal: Neurocrit Care Date: 2009-04-29 Impact factor: 3.210
Authors: Shelly Mathur; Jasmine Boparai; Sanjay N Mediwala; Jose M Garcia; Glenn R Cunningham; Marco Marcelli; Madhuri M Vasudevan Journal: J Investig Med High Impact Case Rep Date: 2014-03-13
Authors: Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy Journal: J Clin Endocrinol Metab Date: 2016-01-13 Impact factor: 5.958
Authors: Mary Ellen Vajravelu; Jared Tobolski; Evanette Burrows; Marianne Chilutti; Rui Xiao; Vaneeta Bamba; Steven Willi; Andrew Palladino; Jon M Burnham; Shana E McCormack Journal: Int J Pediatr Endocrinol Date: 2015-10-22